Stockscreener 앱 받기
23.15
2.03%
-0.48
시간 외 거래:
23.15
Viridian Therapeutics Inc 주식(VRDN)의 최신 뉴스
Smart tools for monitoring Viridian Therapeutics Inc.’s price action2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Viridian Therapeutics submits Biologics License Application to FDA for veligrotug - Ophthalmology Times
Viridian Therapeutics submits BLA for thyroid disease drug - Traders Union
Viridian Therapeutics (VRDN) Submits BLA for Veligrotug to FDA - GuruFocus
Trend analysis for Viridian Therapeutics Inc. this weekWeekly Risk Report & AI Forecast for Swing Trade Picks - newser.com
Can Viridian Therapeutics Inc. stock attract ESG capital inflowsJuly 2025 Pullbacks & Daily Stock Momentum Reports - newser.com
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease - The Joplin Globe
How hedge fund analytics apply to Viridian Therapeutics Inc. stockTrade Ideas & Weekly High Momentum Picks - newser.com
How Viridian Therapeutics Inc. stock reacts to job market dataQuarterly Portfolio Summary & Target Return Focused Picks - newser.com
Can machine learning forecast Viridian Therapeutics Inc. recovery2025 Top Gainers & Weekly High Return Stock Forecasts - newser.com
How buybacks impact Viridian Therapeutics Inc. stock valueJuly 2025 Short Interest & Safe Capital Allocation Plans - newser.com
Can swing trading help recover from Viridian Therapeutics Inc. lossesShare Buyback & Community Consensus Trade Alerts - newser.com
Top chart patterns to watch in Viridian Therapeutics Inc.Rate Cut & High Win Rate Trade Tips - newser.com
Will Viridian Therapeutics Inc. (1S1) stock attract long term capital inflows2025 Key Lessons & Fast Exit and Entry Trade Guides - newser.com
Chart based exit strategy for Viridian Therapeutics Inc.2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
Why Viridian Therapeutics Inc. (1S1) stock is a must watch tickerWeekly Stock Analysis & Verified Chart Pattern Signals - newser.com
Regression analysis insights on Viridian Therapeutics Inc. performanceDay Trade & Free Verified High Yield Trade Plans - newser.com
Is Viridian Therapeutics Inc. stock attractive for growth ETFsSell Signal & Community Consensus Trade Alerts - newser.com
Chart based analysis of Viridian Therapeutics Inc. trendsJuly 2025 Retail & AI Forecasted Entry and Exit Points - newser.com
Oppenheimer Maintains Viridian Therapeutics (VRDN) Outperform Recommendation - MSN
Moody Aldrich Partners LLC Has $1.25 Million Stake in Viridian Therapeutics, Inc. $VRDN - MarketBeat
Reassessing Viridian Therapeutics (VRDN) Valuation Following Insider Buying and Progress in Thyroid Eye Disease Program - Sahm
Astria, Viridian Therapeutics, and More Stocks See Action From Activist Investors - Barron's
Fairmount Funds Management LLC's Strategic Acquisition in Viridi - GuruFocus
Wedbush Reduces Earnings Estimates for Viridian Therapeutics - MarketBeat
How supply chain issues affect Viridian Therapeutics Inc. stock2025 Top Decliners & Free High Return Stock Watch Alerts - newser.com
How Viridian Therapeutics Inc. stock performs in interest rate cyclesEarnings Miss & Consistent Growth Stock Picks - newser.com
Is Viridian Therapeutics Inc. (1S1) stock a buy on weaknessTrade Volume Report & Real-Time Volume Surge Alerts - newser.com
Using Ichimoku Cloud for Viridian Therapeutics Inc. technicalsEarnings Overview Report & Short-Term High Return Ideas - newser.com
Wedbush Expects Reduced Earnings for Viridian Therapeutics - MarketBeat
Can Viridian Therapeutics Inc. (1S1) stock survive global slowdownWeekly Trend Report & Fast Moving Market Watchlists - newser.com
0.64%
0.35%
자본화:
|
볼륨(24시간):